Dramamine Tablet, Chewable
NDC Package 66715-9809-2
Package Information
Dramamine (dimenhydrinate) tablets is dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. This formulation utilizes a tablet, chewable delivery system. Marketed by Lil' Drug Store Products, Inc., this product is identified by NDC 66715-9809 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 309913 - dimenhyDRINATE 50 MG Chewable Tablet
- RxCUI: 309913 - dimenhydrinate 50 MG Chewable Tablet
- RxCUI: 602223 - Dramamine 50 MG Chewable Tablet
- RxCUI: 602223 - dimenhydrinate 50 MG Chewable Tablet [Dramamine]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66715 - Lil' Drug Store Products, Inc.
- 66715-9809 - Dramamine
- 66715-9809-2 - 2 POUCH in 1 CARTON / 2 TABLET, CHEWABLE in 1 POUCH
- 66715-9809 - Dramamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (66715-9809). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66715-9809-2 identifies a specific commercial package of 2 pouch in 1 carton / 2 tablet, chewable in 1 pouch of Dramamine, a human over the counter drug labeled by Lil' Drug Store Products, Inc.. This tablet, chewable is formulated for oral use and contains dimenhydrinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lil' Drug Store Products, Inc. on May 10, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Dimenhydrinate injection should not be used in newborns because of an increased risk of side effects.
How is this Lil' Drug Store Products, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66715980902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.